Gemina Laboratories Ltd.
GLAB
CNSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 20.12% | 43.73% | 46.46% | -58.93% | 11.07% |
| Total Depreciation and Amortization | -5.00% | -90.34% | -2.36% | -1.85% | 10.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 143.48% | -106.91% | -66.19% | 140.83% | -31.38% |
| Change in Net Operating Assets | -7.37% | -39.91% | -37.86% | 90.63% | 9.98% |
| Cash from Operations | 216.36% | -197.27% | 187.30% | 80.47% | 37.92% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | 100.00% | 66.67% | 0.95% | -16.67% |
| Issuance of Common Stock | -- | -100.00% | 400.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -337.70% | 200.00% | -- |
| Cash from Financing | -- | 100.00% | 27.88% | -306.25% | -97.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 146.73% | -314.00% | 134.72% | 76.20% | -180.77% |